These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 37695431)
41. Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study. Aamand T; Fisker AB; Correia C; Fernandes M; Clipet-Jensen C; Thysen SM Hum Vaccin Immunother; 2023 Dec; 19(3):2288297. PubMed ID: 38054431 [TBL] [Abstract][Full Text] [Related]
42. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293 [TBL] [Abstract][Full Text] [Related]
43. Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial. Kelly E; Greenland M; de Whalley PCS; Aley PK; Plested EL; Singh N; Koleva S; Tonner S; Macaulay GC; Read RC; Ramsay M; Cameron JC; Turner DPJ; Heath PT; Bernatoniene J; Connor P; Cathie K; Faust SN; Banerjee I; Cantrell L; Mujadidi YF; Belhadef HT; Clutterbuck EA; Anslow R; Valliji Z; James T; Hallis B; Otter AD; Lambe T; Nguyen-Van-Tam JS; Minassian AM; Liu X; Snape MD; J Infect; 2023 Sep; 87(3):230-241. PubMed ID: 37331429 [TBL] [Abstract][Full Text] [Related]
44. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. Armstrong EP J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326 [TBL] [Abstract][Full Text] [Related]
45. Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents. Jay C; Adland E; Csala A; Lim N; Longet S; Ogbe A; Ratcliff J; Sampson O; Thompson CP; Turtle L; Barnes E; Dunachie S; Klenerman P; Carroll M; Goulder P Front Immunol; 2023; 14():1248630. PubMed ID: 37942333 [TBL] [Abstract][Full Text] [Related]
46. Needle size for vaccination procedures in children and adolescents. Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010720. PubMed ID: 30091147 [TBL] [Abstract][Full Text] [Related]
47. Gender differences in vaccine therapy: where are we in COVID-19 pandemic? Ciarambino T; Barbagelata E; Corbi G; Ambrosino I; Politi C; Lavalle F; Ruggieri A; Moretti A Monaldi Arch Chest Dis; 2021 Apr; 91(4):. PubMed ID: 33840183 [TBL] [Abstract][Full Text] [Related]
48. Effect of gender, age and vaccine on reactogenicity and incapacity to work after COVID-19 vaccination: a survey among health care workers. Nachtigall I; Bonsignore M; Hohenstein S; Bollmann A; Günther R; Kodde C; Englisch M; Ahmad-Nejad P; Schröder A; Glenz C; Kuhlen R; Thürmann P; Meier-Hellmann A BMC Infect Dis; 2022 Mar; 22(1):291. PubMed ID: 35346089 [TBL] [Abstract][Full Text] [Related]
49. Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls. McMahon BJ; Parkinson AJ; Bulkow L; Davidson M; Wainwright K; Wolfe P; Schiffman GS Am J Med; 1993 Dec; 95(6):589-94. PubMed ID: 8259775 [TBL] [Abstract][Full Text] [Related]
50. The impact of vaccines on heterologous adaptive immunity. Messina NL; Zimmermann P; Curtis N Clin Microbiol Infect; 2019 Dec; 25(12):1484-1493. PubMed ID: 30797062 [TBL] [Abstract][Full Text] [Related]
51. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination. Liu F; Gross FL; Jefferson SN; Holiday C; Bai Y; Wang L; Zhou B; Levine MZ J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690218 [TBL] [Abstract][Full Text] [Related]
52. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity. Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J Front Immunol; 2018; 9():3103. PubMed ID: 30761157 [TBL] [Abstract][Full Text] [Related]
53. Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. Burny W; Marchant A; Hervé C; Callegaro A; Caubet M; Fissette L; Gheyle L; Legrand C; Ndour C; Tavares Da Silva F; van der Most R; Willems F; Didierlaurent AM; Yarzabal J; Vaccine; 2019 Mar; 37(14):2004-2015. PubMed ID: 30850240 [TBL] [Abstract][Full Text] [Related]
55. [Technical guidelines for seasonal influenza vaccination in China (2023-2024)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1507-1530. PubMed ID: 37875437 [TBL] [Abstract][Full Text] [Related]
56. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602 [TBL] [Abstract][Full Text] [Related]
57. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)]. National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484 [TBL] [Abstract][Full Text] [Related]